Supreme Court Will Rule On Pedicle Screw "Fraud On The FDA" Case
This article was originally published in The Gray Sheet
Executive Summary
The U.S. Supreme Court should overturn an appeals court decision that federal law does not preempt a claim of "fraud on the FDA" against the Buckman Company, the Office of Solicitor General states in an amicus brief filed with the high court.